A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy
Clinical trial NCT03267303 · COMPLETED
Trial details
- NCT number
- NCT03267303
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2018-12-13
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.